What the Ringling Brothers’ retired elephants have to do with cancer research

When it comes to developing cancer, risk increases with body size and life span, according to the National Institutes of Health. This is because the more cells an organism has, and the longer the organism lives, the greater number of cell divisions it will undergo. Elephants, however, have a lower-than-expected rate of cancer, even though the odds are against them. A research project underway in Florida involving retired circus elephants is working to find out why, Slate reports.

Advertisement

Two of the elephants involved in the project, Julia and Sara, are recent retirees of Ringling Brothers and Barnum & Bailey Circus, which have now stopped using elephants in their performances.

The project is led by Joshua D. Schiffman, MD, a pediatric oncologist, and will be housed at the Center for Elephant Conservation in Polk City, Fla., according to Slate.   The research will focus on the blood of elephants, which contains a gene that suppresses tumor growth, in hopes that a synthetic version might be developed. 

More articles on cancer research:

2 Google and Twitter executives create genetic cancer testing startup 
The importance of community hospitals’ participation in clinical research 
With support of investors, better cancer cures are possible 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Rankings and Ratings

Advertisement

Comments are closed.